Caption Guidance vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Caption Health
VS
by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

These tools are adjacent rather than direct competitors, as they address different stages of cardiac diagnostics and utilize distinct imaging modalities. Caption Guidance assists healthcare providers in real-time acquisition of diagnostic-quality cardiac ultrasound images, focusing on improving image capture. In contrast, Autoplaque performs quantitative post-processing analysis of coronary plaques and stenoses from CT angiography images to aid in risk prediction.

Choose Caption Guidance if…

Choose Caption Guidance if your primary goal is to empower healthcare providers to acquire diagnostic-quality cardiac ultrasound images with real-time AI guidance and automated quality assessment. This tool is ideal for expanding access to critical cardiac diagnostics by enabling a broader range of clinicians to confidently perform echocardiograms, particularly in settings where sonographer expertise may vary or specialized echocardiography resources are limited.

View Caption Guidance →

Choose Autoplaque if…

Choose Autoplaque if you require advanced, quantitative analysis of pre-existing CT angiography images to precisely characterize coronary plaques and luminal stenoses. This workstation-based software is best suited for cardiologists and radiologists seeking detailed insights into atherosclerotic burden for accurate heart attack risk prediction, treatment guidance, and monitoring of coronary artery disease based on CT data.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Caption Guidance Autoplaque
Deployment On-premise (integrated with ultrasound equipment) and cloud-based services. Workstation-based post-processing application, runs on Windows or Mac OS.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Caption Guidance

Caption Guidance provides real-time, turn-by-turn instructions and a quality meter during ultrasound image acquisition, making it accessible even for users without prior ultrasound experience. This direct, in-procedure assistance significantly lowers the learning curve and enhances image accuracy. Autoplaque, while offering automated analysis, is a workstation-based post-processing tool intended for trained medical professionals.

Clinical Value

Autoplaque

Autoplaque offers AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography, providing strong predictive value for myocardial infarction and aiding in treatment guidance. Clinical validation confirms its performance against expert measurements for plaque volume and stenosis. Caption Guidance primarily focuses on improving the acquisition of diagnostic-quality ultrasound images, which is foundational, but Autoplaque moves further into actionable insights for patient management.

Pricing & Value

Caption Guidance

Caption Guidance offers some transparency with a subscription pricing model and an introductory price for a direct-to-patient service, along with CMS NTAP designation that aids hospital reimbursement. Autoplaque's pricing is not disclosed, making it impossible to assess its value proposition.

Enterprise Readiness

Caption Guidance

Caption Guidance, as part of GE HealthCare, benefits from a robust enterprise infrastructure, explicit HIPAA compliance, and a Business Associate Agreement (BAA). Its integration with compatible GE HealthCare ultrasound systems also suggests easier adoption. Autoplaque, developed by Cedars-Sinai AIM, lacks specified BAA and HIPAA compliance in the provided information.

Innovation

Caption Guidance

Caption Guidance is the first FDA-cleared AI-guided software for real-time cardiac ultrasound image acquisition, fundamentally changing who can perform diagnostic-quality echocardiograms. This addresses workforce shortages and expands access to care by democratizing a complex skill. Autoplaque's innovation lies in automating and enhancing the analysis of existing CT images, which is valuable but less disruptive to the initial imaging process.

Support & Docs

Caption Guidance

Caption Guidance, being a GE HealthCare product, is expected to have a more established support and documentation framework, with its user manual accessible directly from the software and a customer support email provided. Autoplaque, from an academic institution, has less explicit information regarding its support channels or comprehensive documentation beyond a user manual.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Caption Guidance Autoplaque
Name Caption Guidance Autoplaque
Company Caption Health (now part of GE HealthCare) Cedars-Sinai Medical Center: AIM
Primary Imaging Modality Cardiac Ultrasound CT Angiography
Core Functionality Real-time AI guidance for ultrasound probe manipulation, automated quality assessment, and auto-capture of diagnostic-quality ultrasound clips. AI-powered quantitative analysis of coronary plaques and luminal stenoses.
Key Output/Measurement Real-time feedback on diagnostic image quality, automated ejection fraction calculation, auto-capture of diagnostic-quality ultrasound clips. Quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, measurement of vessel diameter and area.

Videos

Demos, reviews, and walkthroughs featuring Caption Guidance and Autoplaque.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Caption Guidance is designed for use with cardiac ultrasound systems, providing real-time AI guidance during image acquisition for 2D transthoracic echocardiography (2-D TTE). Autoplaque, in contrast, performs quantitative analysis on CT angiography images to assess coronary plaques and luminal stenoses.
Caption Guidance aims to empower healthcare providers to acquire diagnostic-quality cardiac ultrasound images through real-time guidance and automated quality assessment, addressing the national shortage of cardiac sonographers. Autoplaque focuses on aiding in heart attack risk prediction and treatment guidance by providing AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images.
Caption Guidance provides real-time AI guidance for ultrasound probe manipulation, automated quality assessment with a 'Quality Meter', auto-capture of diagnostic-quality ultrasound clips, and automated ejection fraction calculation. Autoplaque offers AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, and automated vessel, plaque, and lumen segmentation.
Caption Guidance explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place. For Autoplaque, information regarding HIPAA compliance and the availability of a BAA is not specified in the provided details, though a study involving Autoplaque was approved as HIPAA compliant.
AI Tool Finder
AI-powered search. Results may not be comprehensive.